Luxexcel announced that it has received an equity investment of 4M EUR (4.7M USD) from Innovation Industries, a Netherlands based Venture Capital fund.
The investment enables Luxexcel to accelerate the next-gen development of its 3D printing platform for prescription lenses for use in Augmented Reality and Virtual Reality applications.
Earlier, Luxexcel announced a 8.5M EUR (10M USD) investment for its core activities in the ophthalmic industry (including participation from SET Ventures, Munich Venture Partners, PMV and KLA-Tencor). Infoclip recently reported on their partnership North Carolina-based optical lab IFB Solutions.
This new 4 million Euro investment will be used for “rapid expansion of the Luxexcel platform-functionality through dedicated (co-)development programs and partnerships in the domain of Augmented & Virtual Reality also known as AR/VR. AR/VR applications include smart glasses that provide the user with real time information for professional and personal use, gaming applications including control consoles for drones, sensors and cameras integrated in eyewear.”
Hans Streng, Chief Executive Officer of Luxexcel states: “AR/VR applications have become a hot topic in the industry. We add the ability to 3D-print ophthalmic-quality prescription lenses to these applications. This enables the AR/VR headset manufacturers to offer fully personalized smart eyewear in an attractive frame design. The ability of our platform to 3D-print ophthalmic lenses in any shape or form and the possibility to embed new functionalities in the lens triggers entirely new dimensions in terms of user-experience and business opportunity.”
Read more about Luxexcel and 3D printed lenses in October’s Optik magazine.
